Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (original) (raw)

Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)

Neuropharmacology, 2017

5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines

PLOS ONE, 2019

Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor

SHUJIE WANG

Biomolecules & Therapeutics

View PDFchevron_right

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues

David Nichols

ACS chemical neuroscience, 2015

View PDFchevron_right

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

Aaron Janowsky

Psychopharmacology, 2014

View PDFchevron_right

Agonist Properties of N,N-Dimethyltryptamine at Serotonin 5-HT2A and 5-HT2C Receptors

Randy Smith

Pharmacology Biochemistry and Behavior, 1998

View PDFchevron_right

Receptor binding profiles and QSAR of some 5-substituted-N,N-diallyltryptamines.

Nicholas V Cozzi, Ph.D., Paul Daley

Bioorganic and Medicinal Chemistry Letters, 2016

View PDFchevron_right

Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT)2A and 5-HT2C Receptors

Bruce Cassels

Journal of Pharmacology and Experimental Therapeutics, 2007

View PDFchevron_right

1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: A Potent Serotonin 5-HT2A/2C Agonist

David Nichols

Journal of Medicinal Chemistry, 1994

View PDFchevron_right

Functional Selectivity of Hallucinogenic Phenethylamine and Phenylisopropylamine Derivatives at Human 5-Hydroxytryptamine (5-HT) 2A and 5-HT2C …

Pablo Moya

… of Pharmacology and …, 2007

View PDFchevron_right

Receptor binding profiles and quantitative structure–affinity relationships of some 5-substituted-N,N-diallyltryptamines

Paul Daley

Bioorganic & Medicinal Chemistry Letters, 2015

View PDFchevron_right

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Nicholas V Cozzi, Ph.D., Paul Daley

Neuropharmacology, 2018

View PDFchevron_right

Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists

David Nichols

Molecular pharmacology, 2006

View PDFchevron_right

1-Aminomethylbenzocycloalkanes: Conformationally Restricted Hallucinogenic Phenethylamine Analogues as Functionally Selective 5-HT2A Receptor Agonists

David Nichols

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

Binding of Serotonin and N1-Benzenesulfonyltryptamine-Related Analogs at Human 5-HT6 Serotonin Receptors: Receptor Modeling Studies

Richard Glennon

Journal of Medicinal Chemistry, 2008

View PDFchevron_right

In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1

Marius C Hoener

The Journal of pharmacology and experimental therapeutics, 2016

View PDFchevron_right

Mapping the Binding Site Pocket of the Serotonin 5-Hydroxytryptamine2A Receptor. Ser3.36(159) PROVIDES A SECOND INTERACTION SITE FOR THE PROTONATED AMINE OF SEROTONIN BUT NOT OF LYSERGIC ACID DIETHYLAMIDE OR BUFOTENIN

Harel Weinstein

Journal of Biological Chemistry, 1996

View PDFchevron_right

Contribution of serotonin receptor subtypes to hallucinogenic activity of 25I-NBOMe and to its effect on neurotransmission

Monika Sciab

Pharmacological Reports

View PDFchevron_right

(trifluoromethy1)phenyl) -2-aminopropane: A Potent Serotonin ~-HT~A/~c Agonist

stewart frescas

1994

View PDFchevron_right

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

Steve Peroutka

Neuropharmacology, 1990

View PDFchevron_right

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Marius C Hoener

European Neuropsychopharmacology, 2016

View PDFchevron_right

Characterization of a novel and potent 5-hydroxytryptamine1A receptor antagonist

Linda Liau

Pharmacology Biochemistry and Behavior, 1991

View PDFchevron_right

Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin

Dennis McKenna

The Journal of neuroscience : the official journal of the Society for Neuroscience, 1989

View PDFchevron_right

Hallucinogen-like effects of N, N-dipropyltryptamine (DPT): Possible mediation by serotonin 5HT 1A and 5HT 2A receptors in rodents

Haley Yarosh

Pharmacology Biochemistry and Behavior, 2008

View PDFchevron_right

Discovery of N-Substituted 2-Phenylcyclopropylmethylamines as Functionally Selective Serotonin 2C (5-HT2C) Receptor Agonists for Potential Use as Antipsychotic Medications

alan kozikowski

Journal of medicinal chemistry, 2017

View PDFchevron_right

Binding of b-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors

Richard Glennon

1999

View PDFchevron_right

Psychedelic 5-Methoxy-N,N-dimethyltryptamine: Metabolism, Pharmacokinetics, Drug Interactions, and Pharmacological Actions

Emmanuel Mendoza Ibarra

View PDFchevron_right

Pharmacology of a novel selective 5-hydroxytryptamine 1B receptor antagonist, AR-A000002

Carin Wallsten, Teresa Hallerbäck, Carina Stenfors

Naunyn-Schmiedeberg's Archives of Pharmacology, 2004

View PDFchevron_right

N -Methyl-5- tert -butyltryptamine: A Novel, Highly Potent 5-HT 1D Receptor Agonist

James Audia

Journal of Medicinal Chemistry, 1999

View PDFchevron_right

A Behavioural and Biochemical Study in Rats of 5-HYDROXYTRYPTAMINE Receptor Agonists and Antagonists, with Observations on Structure-Activity Requirements for the Agonists

Anthony Rees

British Journal of Pharmacology, 1981

View PDFchevron_right

Novel 4-Substituted-N,N-dimethyltetrahydronaphthalen-2-amines: Synthesis, Affinity, and In Silico Docking Studies at Serotonin 5-HT2-type and Histamine H1 G Protein-Coupled Receptors

Khalil Abboud

Bioorganic & Medicinal Chemistry, 2015

View PDFchevron_right

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2R,3R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Malath Makhay

Journal of Pharmacology and Experimental Therapeutics, 2006

View PDFchevron_right

Pharmacological Characterization of AC-90179 [2-(4-Methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide Hydrochloride]: A Selective Serotonin 2A Receptor Inverse Agonist

Malath Makhay

Journal of Pharmacology and Experimental Therapeutics, 2004

View PDFchevron_right

Optimization of 2-Phenylcyclopropylmethylamines as Selective Serotonin 2C Receptor Agonists and Their Evaluation as Potential Antipsychotic Agents

Patrick Giguere, Oluseye Onajole

Journal of Medicinal Chemistry, 2015

View PDFchevron_right

Distinct Molecular Recognition of Psychostimulants by Human andDrosophilaSerotonin Transporters

David Nichols

Journal of Pharmacology and Experimental Therapeutics, 2003

View PDFchevron_right

Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs) (original) (raw)

Related papers